


| Key | % Net Assets |
|---|---|
| 8.8% | |
| 7.5% | |
| 4.0% | |
| 3.6% | |
| 76.1% |
| Name | % Net Assets |
|---|---|
| Roche | 8.8% |
| Novartis | 7.5% |
| Koninklijke KPN | 4.0% |
| TNT | 3.6% |
| Zurich Financial Services | 3.2% |
| Vivendi Universal | 3.2% |
| Thales | 3.1% |
| Carrefour | 3.0% |
| Group 4 Securicor | 3.0% |
| CRH | 2.9% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 214.78p |
| Currency | GBP |
| Change | 0.67p |
| % | 0.31% |
| YTD change | 37.66p |
| YTD % | 21.26% |
| Fund Inception | 18/01/1986 |
|---|---|
| Fund Manager | Jeffrey Taylor |
| TER | 1.19 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.18% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research